Thalidomide in Patients with Transfusion-Dependent E-Beta Thalassemia Refractory to Hydroxyurea: A Single-Center Experience
暂无分享，去创建一个
[1] K. Ghosh,et al. Genetic determinants related to pharmacological induction of foetal haemoglobin in transfusion-dependent HbE-β thalassaemia , 2018, Annals of Hematology.
[2] Yan Ma,et al. Clinical trial on the effects of thalidomide on hemoglobin synthesis in patients with moderate thalassemia intermedia , 2018, Annals of Hematology.
[3] Lan Huang,et al. Thalidomide induces haematologic responses in patients with β‐thalassaemia , 2017, European journal of haematology.
[4] R. Antaya,et al. Review of thalidomide use in the pediatric population. , 2015, Journal of the American Academy of Dermatology.
[5] B. Pace,et al. Fetal Hemoglobin Induction to Treat b-Hemoglobinopathies : From Bench to Bedside , 2014 .
[6] E. Vichinsky,et al. Hb E/beta-thalassaemia: a common & clinically diverse disorder , 2011, The Indian journal of medical research.
[7] D. Weatherall,et al. Fetal haemoglobin augmentation in E/β0 thalassaemia: clinical and haematological outcome , 2005, British journal of haematology.
[8] D J Weatherall,et al. Inherited haemoglobin disorders: an increasing global health problem. , 2001, Bulletin of the World Health Organization.